The anti-non-small cell lung cancer effect of Diosbulbin B: Targeting YY1 induced cell cycle arrest and apoptosis.
Scientists studied Diosbulbin B (DIOB) from Dioscorea bulbifera L. as a potential anti-cancer drug. DIOB shows promise in treating non-small cell lung cancer (NSCLC) at safe doses, but further research is needed.
- Zhao JQ et al (2024).
- Phytomedicine.
- PubMed:
- 38761775